Laurène Froment

498 total citations
14 papers, 407 citations indexed

About

Laurène Froment is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Laurène Froment has authored 14 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Laurène Froment's work include Lung Cancer Treatments and Mutations (5 papers), Cancer Cells and Metastasis (4 papers) and Cancer therapeutics and mechanisms (2 papers). Laurène Froment is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Cancer Cells and Metastasis (4 papers) and Cancer therapeutics and mechanisms (2 papers). Laurène Froment collaborates with scholars based in Switzerland, Germany and United States. Laurène Froment's co-authors include Ralph A. Schmid, Thomas M. Marti, Ren‐Wang Peng, Patrick Dorn, Lourdes Cortes‐Dericks, Gregor J. Kocher, Sabina Berezowska, Golnaz Karoubi, Shun‐Qing Liang and Sean R. R. Hall and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Scientific Reports.

In The Last Decade

Laurène Froment

14 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurène Froment Switzerland 9 182 179 141 78 51 14 407
Durga Attili United States 11 199 1.1× 111 0.6× 88 0.6× 111 1.4× 35 0.7× 16 436
Daniel Mendoza-Posada Mexico 4 165 0.9× 200 1.1× 122 0.9× 127 1.6× 32 0.6× 5 417
Yongqing Gu China 15 357 2.0× 132 0.7× 140 1.0× 125 1.6× 27 0.5× 35 565
Oliver Delgado United States 9 239 1.3× 91 0.5× 113 0.8× 111 1.4× 28 0.5× 12 440
Yajie Wang China 11 213 1.2× 105 0.6× 189 1.3× 129 1.7× 32 0.6× 27 474
Hyeryeong Kim South Korea 6 328 1.8× 221 1.2× 105 0.7× 182 2.3× 40 0.8× 10 583
Dongdong Luo China 11 219 1.2× 121 0.7× 67 0.5× 121 1.6× 35 0.7× 27 387
Qifeng Ding China 10 130 0.7× 169 0.9× 149 1.1× 86 1.1× 34 0.7× 22 386
Grace L. Wong United States 9 341 1.9× 229 1.3× 77 0.5× 150 1.9× 34 0.7× 13 578

Countries citing papers authored by Laurène Froment

Since Specialization
Citations

This map shows the geographic impact of Laurène Froment's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurène Froment with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurène Froment more than expected).

Fields of papers citing papers by Laurène Froment

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurène Froment. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurène Froment. The network helps show where Laurène Froment may publish in the future.

Co-authorship network of co-authors of Laurène Froment

This figure shows the co-authorship network connecting the top 25 collaborators of Laurène Froment. A scholar is included among the top collaborators of Laurène Froment based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurène Froment. Laurène Froment is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sengupta, Arunima, Nuria Roldán, Mirjam Kiener, et al.. (2022). A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System. SHILAP Revista de lepidopterología. 4. 840606–840606. 40 indexed citations
2.
Wang, Limei, Patrick Dorn, Cédric Simillion, et al.. (2020). EpCAM+CD73+ mark epithelial progenitor cells in postnatal human lung and are associated with pathogenesis of pulmonary disease including lung adenocarcinoma. American Journal of Physiology-Lung Cellular and Molecular Physiology. 319(5). L794–L809. 7 indexed citations
3.
Wang, Limei, Patrick Dorn, Laurène Froment, et al.. (2020). CD90+CD146+ identifies a pulmonary mesenchymal cell subtype with both immune modulatory and perivascular-like function in postnatal human lung. American Journal of Physiology-Lung Cellular and Molecular Physiology. 318(4). L813–L830. 13 indexed citations
4.
Roldán, Nuria, Laurène Froment, Thomas M. Marti, et al.. (2020). Interleukin-2 – induced vascular leak syndrome: clinically relevant in vitro recapitulation with a patient-derived lung-on-chip. 4326–4326. 5 indexed citations
5.
Gao, Yanyun, Nina Hobi, Sabina Berezowska, et al.. (2018). Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549. Neoplasia. 21(2). 185–196. 46 indexed citations
6.
Liang, Shun‐Qing, Sabina Berezowska, Thomas M. Marti, et al.. (2018). mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer. Oncogene. 38(5). 622–636. 45 indexed citations
7.
Bichsel, Colette A., Limei Wang, Laurène Froment, et al.. (2017). Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model. Scientific Reports. 7(1). 10636–10636. 35 indexed citations
8.
9.
10.
Liang, Shun‐Qing, Thomas M. Marti, Patrick Dorn, et al.. (2016). 18P Epithelial-to-mesenchymal transition (EMT) is required for resistance to anti-folate chemotherapy in lung cancer. Journal of Thoracic Oncology. 11(4). S63–S63. 2 indexed citations
11.
Cortes‐Dericks, Lourdes, Laurène Froment, Gregor J. Kocher, & Ralph A. Schmid. (2016). Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines. Stem Cell Research & Therapy. 7(1). 25–25. 26 indexed citations
12.
13.
Liang, Shun‐Qing, Thomas M. Marti, Patrick Dorn, et al.. (2015). Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer. Cell Death and Disease. 6(7). e1824–e1824. 69 indexed citations
14.
Cortes‐Dericks, Lourdes, et al.. (2014). Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity. BMC Cancer. 14(1). 304–304. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Durga Attili Breakdown of academic impact, for papers by Daniel Mendoza-Posada Breakdown of academic impact, for papers by Yongqing Gu Breakdown of academic impact, for papers by Oliver Delgado Breakdown of academic impact, for papers by Yajie Wang Breakdown of academic impact, for papers by Hyeryeong Kim Breakdown of academic impact, for papers by Dongdong Luo Breakdown of academic impact, for papers by Qifeng Ding Breakdown of academic impact, for papers by Grace L. Wong
Rankless by CCL
2026